| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And Exe. Chair Of Board | CEO And Executive Cob
2 companies
Stockwell Lynn is a CEO And Exe. Chair Of Board at Drugs Made In America Acquisition II Corp. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 2 sells.
Estimated insider holdings value: $194.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2025 | DMII Drugs Made In America Acquisition II Corp. | CEO And Exe. Chair Of Board | Buy | 700,000 | $0.00 | - | +4.9% | |
| Sep 26, 2025 | DMII Drugs Made In America Acquisition II Corp. | CEO And Exe. Chair Of Board | Sell | 7,966,667 | $0.00 | - | -54.3% | |
| Feb 18, 2025 | DMAA Drugs Made In America Acquisition Corp. | CEO And Exe. Chair Of Board | Buy | 30,000 | $0.00 | - | +0.7% | |
| Jan 29, 2025 | DMAA Drugs Made In America Acquisition Corp. | CEO And Executive Cob | Buy | 400,000 | $0.00 | - | -102.6% | |
| Jan 29, 2025 | DMAA Drugs Made In America Acquisition Corp. | CEO And Executive Cob | Sell | 5,698,363 | $0.00 | - | -57.8% |